Central European tick-borne encephalitis (TBE) is caused by a flavivirus vectored by the Ixodes ricinus tick. In severe infections, TBE presents as (myelo)meningoencephalitis with considerable mortality. Characteristic neuropathologic changes feature a multinodular to patchy polioencephalomyelitis accentuated in spinal cord, brainstem, and cerebellum. Visualization of viral infection by immunohistochemistry has not yet been achieved. We analyzed immunohistochemically the distribution of viral antigens and its correlation with neuropathologic changes, serological data, and disease duration in 28 brains of cases with a clinical diagnosis of TBE and neuropathologically confirmed (meningo)encephalomyelitis. In 20 brains (including 10 seropositives), viral antigens were detectable. These cases were characterized by relatively short clinical duration ranging from 4 to 35 days. Immunoreactivity was most prominent in perikarya and processes of Purkinje cells and large neurons of dentate nucleus, inferior olives, and anterior horns. In addition, immunoreactivity was detected in neurons of other brainstem nuclei, isocortex, and basal ganglia. There was an inverse topographical association of severe inflammatory changes with presence of viral antigens. Some cytotoxic T cells were in direct contact with tick-borne encephalitis virus (TBEV)-infected neurons. We conclude that 1) TBE viral antigens are immunohistochemically detectable in brains of fatal cases with relatively short natural clinical course; 2) TBE virus neurotropism preferentially targets large neurons of anterior horns, medulla oblongata, pons, dentate nucleus, Purkinje cells, and striatum; 3) topographical correlation between inflammatory changes and distribution of viral antigens is poor; and 4) immunologic mechanisms may contribute to nerve cell destruction in human TBE.
INTRODUCTION
Central European tick-borne encephalitis (TBE) is a viral (myelo)meningoencephalitis affecting about 3,000 human cases annually (1, 2) . It is caused by the tick-borne encephalitis virus (TBEV), a flavivirus vectored by the Ixodes ricinus tick, and is endemic in specific areas of Europe (3) . Clinical symptoms occur 1 to 3 weeks after infection by a tick bite. TBE usually features a biphasic course with an initial influenza-like syndrome and a second phase with CNS involvement (1, 4, 5) . Because of nonspecific clinical features, diagnosis of TBE must be established by laboratory methods (4, 5) . The method of choice is the demonstration of specific IgM antibodies in the sera of patients (5) .
Approximately one fourth of patients completely recover within 2 months, while up to 46% of patients are left with permanent neurologic or neuropsychologic sequelae at long-time follow up (1) . Fatal disease courses occur in 0.2% to 6.3% of cases (1, 6) .
Characteristic, although not disease-specific neuropathologic changes include meningitis and multinodular to patchy polioencephalomyelitis accentuated in spinal cord, brainstem, and cerebellum (7) (8) (9) (10) (11) (12) . Definite postmortem diagnosis of TBE may be established by the demonstration of viral presence in CNS tissue, for example, by polymerase chain reaction (PCR) or virus isolation. Immunohistochemical visualization of viral antigens (a convenient method routinely used for the diagnosis of various other viral CNS infections [13] ) has not been achieved for TBEV in human tissue so far. In this study we used a noncommercial hyperimmune polyclonal rabbit serum to immunohistochemically demonstrate the presence of TBEV antigens in historical fatal human cases. We studied the distribution of viral antigens in relation to neuropathologic changes, serological data, and disease duration.
MATERIALS AND METHODS

Patients
A total of 28 autopsy cases were included in this study. Cases were retrospectively collected since 1959 from the archives of the Institute of Neurology of Vienna (22 cases) and from the Markusovszky Hospital, Szombathely, Hungary (6 cases). Inclusion criteria comprised a typical clinical history of TBE in combination with highly suggestive neuropathologic changes. Clinical data are shown in Table 1 . In 17/28 cases acute TBE had been proven by demonstration of specific anti-TBEV IgM antibodies in the patient serum. In 11/28 cases no information on serology was available. Serological data were obtained by hemagglutination inhibition test in combination with the 2-mercaptoethanol (2-ME) reduction method or enzyme-linked immuno-sorbent-assay (ELISA). Available brain areas of cerebral cortex, hippocampus, basal ganglia, and representative samples of brainstem, including medulla oblongata at the level of the inferior olives, pons, midbrain, spinal cord, and cerebellum, including cortex and dentate nucleus, and peripheral nerve were collected. As historical cases were used in this retrospective study, not all brain areas were available in all cases (Tables 1 and 2) .
Histology, Immunohistochemistry, and Double Immunofluorescent Labeling
Brain tissues were routinely formalin-fixed and paraffinembedded. Of each block 3-to 5-mm-thick sections were obtained. Hematoxylin and eosin (H&E) and Klüver-Barrera stainings were performed for standard histopathologic evaluation. For immunohistochemical detection of TBEV antigens a noncommercial rabbit polyclonal hyperimmune serum (Institute of Virology, Medical University of Vienna, Austria; dilution 1:1000) was used. For its production, 140 micrograms of highly purified TBEV strain Hochosterwitz (14) were twice injected, once suspended in complete and once in incomplete Freund's adjuvant, into a rabbit with an interval of 49 days.
Serum of the rabbit was harvested 14 days later and was tested for functional activity using a TBEV hemagglutination inhibition test (titer 1:2560) and for specificity using a TBEV neutralization test (titer 1:40).
In addition, anti-LCA (M0701; 1:1000; DAKO, Glostrup, Denmark), anti-CD3 (A452; 1:500; DAKO), anti-CD4 (M0716; 1:50; DAKO), anti-CD8 (M7103; 1:100; DAKO), anti-CD20 (M0755; 1:200; DAKO), anti-CD79A (M7050; 1:50; DAKO), anti-CD68 (M814; 1:100; DAKO), and anti-HLA-DR (M0775; 1:100; DAKO) immunostainings were performed for characterization of inflammatory infiltrates in the spinal cord of cases 1, 15, and 20.
Tissue section pretreatment for antigen retrieval was performed by boiling sections in 10 mM citrate buffer at pH6 for 10 minutes or by protease XXIV 0.03% digestion at 37°C.
Detection of immunostaining was performed using the Envision Ò kit and diaminobenzidine was used as chromogen. For double immunolabeling, the fluorescent labeled secondary antibody for TBEV was Alexa Fluor 546 goat antimouse IgG (1:200, Molecular Probes, Inc., Eugene, OR) and for CD8 Alexa Fluor 488 goat anti-mouse IgG (1:200, Molecular Probes, Inc.). We used argon 488-nm and 543-nm lasers to elicit immunofluorescent staining. Immunofluorescence labeling was evaluated using a Zeiss LSM 510 laser scanning confocal microscope.
As positive control for anti-TBEV immunohistochemistry we used brain tissue of an experimentally TBEV infected mouse. The animal was subcutaneously inoculated into the skin of the neck with 0.2 mL of 1000 plaque-forming units of highly virulent TBEV. The animal was sacrificed at 11 days postinoculation. The brain tissue immunohistochemically showed abundant TBEV (Fig. 1D) . As negative control specimens we used routinely formalin-fixed and paraffin-embedded samples of frontal cortex from 5 human autopsy cases without history of neurologic disease or histopathologic changes. In addition, we included tissue samples of various human viral encephalitides with typical morphologic changes and immunohistochemical demonstration of the respective viral antigens (one case each): varicella-zoster encephalitis, herpes-simplex encephalitis, cytomegalovirus encephalitis, human immunodeficiency virus encephalitis, subacute sclerosing panencephalitis, and progressive multifocal leukoencephalopathy. None of the negative control cases showed anti-TBEV immunoreactivity. Control of antibody specificity included omission or substitution of the primary antibody by normal rabbit serum.
Evaluation
Severity of inflammation was evaluated semiquantitatively in each sampled brain area and was assessed as follows: negative = no inflammation; sparse = slight inflammatory infiltrates; and prominent = prominent inflammatory infiltrates.
The amount of anti-TBEV immunolabeling was evaluated semiquantitatively in each sampled brain area and was assessed as follows: negative = no immunolabeling; sparse = few immunolabeled neuronal processes and/or perikarya; and prominent = many immunolabeled neuronal processes and/or perikarya. For each sampled brain area the percentage of positive samples per number of available samples of the respective brain region was calculated. Severity of inflammation, In each box, semiquantitative results of inflammation are given on the left side and results of anti-TBEV immunolabeling on the right side (inflammation/immunohistochemistry). Within specimens showing both inflammation and TBEV detectability, areas with prominent inflammation contain only sparse anti-TBEV-immunolabeled structures and vice versa. The fraction of samples with immunohistochemically detectable TBEV antigens per number of available samples of a given region is given as percentage.
2, negative; +, sparse; ++, prominent; na, not available; ah, Ammon's horn; ctx, cortex; dent, dentate nucleus; dienc, diencephalon; striat, striatum; tegm, tegmentum; tect, tectum; thal, thalamus. amount and distribution of immunolabeling, serological data, and disease duration were correlated.
In each of 3 selected cases (cases 1, 15, and 20), we evaluated 20 anti-CD8-immunoreactive cells in areas with prominent inflammation for contact with TBEV-immunoreactive cellular structures on double immunofluorescent labeled sections using confocal laser scanning microscopy.
RESULTS
Gross and Histological Findings
Macroscopically, most cases showed mild to severe hyperemia of parenchyma and leptomeninges, diffuse swelling, and petechial bleedings in cerebrum, brainstem, and spinal cord.
Microscopically, all cases showed variably pronounced polioencephalomyelitis and meningitis characterized by multinodular to patchy mononuclear infiltrates with perivascular lymphocytic cuffing. In addition, there was astroglial and microglial proliferation with formation of glial nodules. Edematous changes with vacuolation of neuropil and of white matter were seen in all cases. Results of the semiquantitative evaluation of inflammatory changes and their correlation with disease duration are shown in Table 2 . In short, widespread distribution of inflammatory changes with accentuation in anterior horns ( Fig. 2A) , brainstem, cerebellum, and basal ganglia was observed. Anterior horns of spinal cords showed marked inflammatory infiltrates ( Fig. 2A) and neuronophagias in cases with short clinical duration, whereas in cases with longer disease duration pronounced gliosis and neuronal loss could be observed. The midbrain showed predominant involvement of substantia nigra with loss of pigmented neurons. In the cerebellum, neuronophagias of Purkinje cells and Bergmann gliosis were commonly seen. The maximum of inflammatory changes was seen at 10 days.
Immunohistochemistry
Anti-TBEV immunolabeling was detectable in neuronal perikarya and processes in 20/28 cases (Fig. 1) . Glial, ependymal, choroidal, or endothelial cells were not immunolabeled. There was also no immunoreactivity in meningeal structures, peripheral nerve, or blood cells. Results of immunohistochemical analyses and their correlation with disease duration, serological findings, and inflammatory changes are given in Tables 1 and 2 . Generally, in positive cases detectability of viral antigens in spinal cord, brainstem, cerebellum, and basal ganglia was widespread. Prominent labeling of many neurons was consistently found in anterior horns, Purkinje cells (Fig. 1A, B) , dentate nucleus, tegmentum of medulla oblongata (inferior olives, raphe nuclei, and formatio reticularis), pontine nuclei and tegmentum of pons (L. coeruleus, N. dorsalis n. vagi, and formatio reticularis), and caudate nucleus. Large neurons were preferentially immunolabeled. Positive cases had maximal disease duration of 35 days. The maximal distribution of immunolabeled structures was found between 6 and 13 days.
Inflammatory changes and immunocytochemical detectability of TBEV showed similar predilection sites but inverse topographical correlation. Within affected regions, areas with prominent inflammatory infiltrates and marked neuronal damage contained only few immunolabeled structures. In these areas only few decorated neuronal processes or immunolabeled neuronophagias were observed (Fig. 1C, G, H) . In contrast, strongly decorated intact neurons typically showed only scarce inflammatory infiltrates of the immediate surroundings (Fig. 1E, F) .
Immunohistochemical characterization of inflammatory infiltrates in the spinal cord of 3 cases with different disease duration showed predominance of T cells and of macrophages/microglia and only few B cells. Anti-CD3 showed scattered T cells in the parenchyma. CD4-and CD8-expressing cells (Fig. 2D) were present in approximately equal amounts. Evaluating the spatial association of cytotoxic T cells with TBEV-infected neurons, we found 3/20 (15%), 6/20 (30%), and 9/20 (45%) anti-CD8-immunoreactive cells in close contact with TBEV-immunoreactive cellular structures in cases 1, 15, and 20, respectively (Fig. 3) . CD20-and CD79a-expressing B cells were absent in case 1. In cases 15 and 20, B cells were mainly confined to perivascular lymphocytic cuffs (Fig. 2E ). There were large amounts of anti-CD68 and anti-HLA-DR-immunoreactive macrophages/microglia in inflammatory foci (Fig. 2B, C, F) . Anterior roots showed prominent infiltration by CD68-and HLA-DR-expressing cells, while posterior roots were spared (Fig. 2B, C) . Results of evaluation of anti-TBEV immunolabeling and inflammatory changes are shown in Table 2 .
DISCUSSION
For the first time, immunohistochemical visualization of TBEV infection is achieved here in fatal human cases of Central European TBE. We demonstrate anti-TBEV immunolabeling of neuronal processes and perikarya and thus show selective tropism of TBEV to neurons in humans. We observe predominant labeling of large neurons, which is in line with previous reports of preferential targeting of large neurons by inflammatory cells (8) . In contrast to a previous description of ultrastructurally detectable viral particles in glial cells in TBE (15), we did not observe immunolabeling of glial cells. We also could not demonstrate anti-TBEV immunolabeling of endothelial cells, which is in contrast with experimental studies suggesting virus replication in endothelial cells as a possible way of neuroinvasion (1, 16) . However, our data show relatively widespread distribution of TBEV antigens already in early disease stages, supporting a hematogenous mode of neuroinvasion. We show that anti-TBEV immunolabeling is most consistently found in anterior horns, medulla oblongata, pons, cerebellum (including cortex and dentate nucleus), and striatum. These regions have been described to be preferentially affected by inflammatory changes in TBE (7) (8) (9) (10) (11) (12) . In contrast to previous descriptions of severe inflammation of the cerebral cortex, we find only slight inflammatory changes of the cerebral cortex in approximately one third of our cases. TBEV antigen was only detected in few dispersed isocortical neurons in few cases. Although inflammation of the meninges is a common feature of TBE we could not detect TBEV in meningeal structures.
We observe inverse topographical correlation of inflammation and detectability of TBEV within affected regions. Areas with prominent inflammatory infiltrates and marked neuronal damage contain only few immunolabeled structures including neuronophagias. Prominent inflammatory infiltrates are predominantly composed of T cells and macrophages/microglia. B cells are only rarely found. These findings correspond to the situation found in other viral encephalitides (17, 18) . Areas with strongly decorated intact neurons typically show only scarce inflammatory infiltrates. In these areas, we demonstrated cytotoxic T cells closely associated with cell membranes of TBEV antigen containing neurons. It is not known whether neuronal cell death is due to the direct effect of the viral infection (''lytic infection'') or is an immunologically mediated process. Although our findings suggest that immunologic mechanisms may contribute to nerve cell destruction in human disease, further studies for detailed characterization of cell death mechanisms are needed.
Analyzing the correlation with disease duration, we found maximal inflammatory changes around the tenth day. Maximal immunohistochemical detectability of TBE viral antigens was between 6 and 13 days. These data correlate with the optimal detectability of IgM and IgG antibodies in CSF around the tenth day (5).
We consider anti-TBEV immunohistochemistry a useful tool for postmortem diagnosis of TBE. Due to the time course of virus detectability, immunohistochemistry is most suitable for diagnosis of acute TBE with disease duration of less than approximately 4 weeks. In accordance with the preferential involvement of the anterior horns, medulla oblongata, pons, and cerebellum, including cortex, dentate nucleus, and striatum, these areas should be preferentially sampled in TBE suspected autopsy cases. Nevertheless, in 2/17 cases with serologically confirmed TBEV infection we could not detect viral antigens immunohistochemically in the brain tissue. Thus, negative immunohistochemistry, as in other viral encephalitides, does not exclude the possibility of TBEV infection. Therefore, at diagnostic work-up of TBE suspected cases, negative immunohistochemistry should be followed by more sensitive methods of virus demonstration, e.g. PCR or virus isolation.
In summary, we show that 1) TBE viral antigens are immunohistochemically detectable in brains of fatal cases with short clinical course, making immunohistochemistry a useful tool for research and diagnosis of TBE; 2) TBE virus neurotropism preferentially targets large neurons of anterior horns, medulla oblongata, pons, dentate nucleus, Purkinje cells, and striatum; 3) topographical correlation between inflammatory changes and distribution of viral antigens is poor; and 4) immunologic mechanisms may contribute to nerve cell destruction in human TBE.
